- Vaccine Results Expected to Give Stock Market a LiftNewser
- Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune ResponseBloomberg
- Moderna skyrockets 39% after its early trial for a coronavirus vaccine produced antibodies in all 45 pati..Business Insider
- Moderna’s stock soars on positive early-stage data for its coronavirus vaccine candidateMarketWatch
- Moderna stock jumps after a positive vaccine trialmsnNOW
- View Full Coverage on Google News